Nasopharyngeal carcinoma staging uses the TNM staging system with derived stage groupings.
Primary tumour (T)
Tx: primary tumour cannot be assessed
T0: no evidence of primary tumour
Tis: carcinoma in situ
T1: tumour is confined to the nasopharynx
T2: tumour extends to soft ti...
Necrotising enterocolitis (NEC) can be staged into three groups, helping to guide appropriate treatment. In general, stage I and II are managed medically whereas stage III is managed surgically.
lethargy, temperature instability, apnoea, bradycardia
emesis, abdominal d...
There are two methods of neuroblastoma staging, one that is based on post-operative patients (INSS) and one developed for pre-treatment patients (INRGSS).
International Neuroblastoma Staging System (INSS)
This staging system is for post-operative patients and mainly for prognosis 1:
The IASLC 8th edition lung cancer staging system was introduced in 2016 and supercedes the IASLC 7th edition.
It is as follows:
T: primary tumour
Tx: primary tumour cannot be assessed or tumour proven by presence of malignant cells in sputum or bronchial washings but not visualis...
Non-small cell lung cancer (NSCLC) staging can be accomplished both by the TNM system or by the AJCC staging system.
This staging has since been revised. See IASLC 8th edition staging.
For a general discussion of these tumours please refer to the article on non-small cell lung cancer (NSCLC).